Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence
|ClinicalTrials.gov Identifier: NCT01528748|
Recruitment Status : Active, not recruiting
First Posted : February 8, 2012
Last Update Posted : October 27, 2016
|Condition or disease||Intervention/treatment|
|Depressive Disorder Major Depressive Disorder Dysthymic Disorder Alcohol-Related Disorders Alcoholism||Behavioral: Cognitive Behavioral Analysis System of Psychotherapy|
|Study Type :||Observational|
|Actual Enrollment :||8 participants|
|Official Title:||Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence|
|Study Start Date :||April 2011|
|Actual Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||July 2018|
Chronically Depressed, Alcohol Dependent
Participants who have been formally diagnosed with a clinical diagnosis of Chronic Depression and Alcohol Dependence.
Behavioral: Cognitive Behavioral Analysis System of Psychotherapy
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a behavioral intervention that addresses the unique behavioral characteristics of chronically depressed individuals, most of which are highly relevant for alcoholics as well. CBASP has a structured, individualized, and collaborative (patient and clinician) design. The intervention emphasizes teaching effective coping strategies and employing motivational, cognitive, behavioral, and interpersonal techniques. Individual therapy (1 hour) sessions occur on a weekly basis for a total of 20 sessions over a period of 21 weeks.
Other Name: CBASP
- Depression Rating [ Time Frame: Baseline and 20 weeks ]Change in depression rating scale over time.
- Drinking behavior [ Time Frame: Baseline and 20 weeks ]Change in number of drinks consumed per day over time.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01528748
|United States, Virginia|
|University of Virginia Center for Addiction Research & Education (UVa CARE)|
|Charlottesville, Virginia, United States, 22911|
|Principal Investigator:||Jennifer K. Penberthy, Ph.D.||University of Virginia, School of Medicine, Department of Psychiatry & Neurobehavioral Sciences|